Manuel Battegay - Biography#

Manuel Battegay is Chief of the Division of Infectious Diseases & Hospital Epidemiology, acting Chief of Medicine with 19 clinics and Professor of Internal Medicine & Infectious Diseases at the University Hospital, University of Basel, Switzerland. He has co-authored over 400 scientific papers cited in Pub-Med in the field of HIV-Medicine and general Infectious Diseases (h-index >60).

Manuel Battegay has studied Medicine in Basel/Switzerland and as an extern at the Maimonides Medical Center, Brooklyn, New York. He received his MD degree in 1985 from the University of Basel. He then worked in Internal Medicine and Infectious Diseases in the Canton Hospital Liestal and University Hospital Zurich. He is board certified in Switzerland in Internal Medicine and Infectious Diseases. From 1990 to 1994 he worked in basic research in the field of viral immunology on the LCM Virus and hepatitis C in the laboratories of Rolf M. Zinkernagel at the Institute of Experimental Pathology, University Zürich and of Jay H. Hoofnagle and Stephen M. Feinstone at the Liver Diseases Section, National Institutes of Health, Bethesda, Maryland, USA. His scientific work in these laboratories included the description of CD8 exhaustion upon viral infection in a mouse model lacking CD4 T-cells and the first description of HCV epitopes. From 2002 onwards, he has been the Head of the Division of Infectious Diseases and Hospital Epidemiology at the University Hospital in Basel/Switzerland. The Division is responsible for the consultation service for patients with mostly severe infectious diseases from all divisions, including surgical ones of the University Hospital Basel, as well as responsibilities for the region regarding hospital epidemiology and nosocomial infection. Associated with this clinical task are appointments for teaching and education, as well as research and research management.

As a clinician and clinical researcher, Manuel Battegay has been active in the field of HIV/AIDS since 1988, particularly with an interest in the clinical course of HIV, namely the response to therapy and immune reconstitution as well as on psychosocial issues. Since 1994 he is a board member of the Swiss HIV Cohort Study (SHCS) Group. He chaired the Scientific Board of the SHCS for four years on a rotational basis from 1998-2002. In the context of the SHCS he contributed to and performed many research projects, be it on epidemiological, clinical or applied basic research questions. Since 2006 he is a member of the Governing Board of the European AIDS Clinical Society (EACS), from 2008-2012 he was Vice-president and since 1.12.2012 he acts as President of EACS. He was co-chair of the 14th and 15th EACS Conference in Brussels 2013 and Barcelona in 2015, respectively and many other meetings and symposia. Within the European AIDS Treatment Network (NEAT) he was chair of the education and training work package. He is a faculty member of International Antiviral Society-USA and member of the scientific committee of the biennial Glasgow International Congress on Drug Therapy in HIV Infection. Together with the Swiss Tropical and Public Health Institute he actively participated in the up-building of a large rural HIV Clinic at the St. Francis Referral Hospital Ifakara, in Tanzania.

For many years he has also been interested in other research related to infectious diseases such as tuberculosis, influenza and clinically related questions to bacterial diseases. His HIV research at the moment focuses on improving the response to antiviral therapy, specifically immune reconstitution and aspects related directly to HIV antiviral therapy.

Imprint Privacy policy « This page (revision-4) was last updated on Monday, 19. December 2016, 12:29 by Kaiser Dana
  • operated by